AJP - GI Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (April 30, 2009). doi:10.1152/ajpgi.00072.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/1/G215    most recent
00072.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larauche, M.
Right arrow Articles by Tache, Y. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larauche, M.
Right arrow Articles by Tache, Y. F.
Submitted on February 27, 2009
Revised on April 27, 2009
Accepted on April 28, 2009

Cortagine, a CRF1 agonist, induces stress-like alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways

Muriel Larauche1*, Guillaume Gourcerol2, Lixin Wang3, Karina Pambukchian3, Stefan Brunnhuber3, David W. Adelson4, Jean Rivier5, Mulugeta Million3, and Yvette F. Tache6

1 UCLA - Center for Neurobiology of Stress
2 University of Rouen
3 UCLA
4 VAGLAHS
5 3The Clayton Foundation Laboratories for Peptide Biology
6 University of California, Los Angeles

* To whom correspondence should be addressed. E-mail: mlarauche{at}mednet.ucla.edu.

Corticotropin-releasing factor (CRF) 1 receptor (CRF1) activation in the brain is a core pathway orchestrating the stress response. Anatomical data also support the existence of CRF signaling components within the colon. We investigated the colonic response to intraperitoneal (i.p.) injection of cortagine, a newly developed selective CRF1 peptide agonist. Colonic motor function and visceral motor response (VMR) were monitored using a modified miniaturized pressure transducer catheter in adult conscious male SD rats and C57Bl/6 mice. Colonic permeability was monitored by the Evans blue method and myenteric neurons activation by Fos immunohistochemistry. Compared to vehicle, cortagine (10 µg/kg, i.p.) significantly decreased the distal colonic transit time by 45% without affecting gastric transit, increased distal and transverse colonic contractility by 35.6% and 66.2% respectively, induced a 7.1-fold increase in defecation and watery diarrhea in 50% of rats during the 1st h post injection while i.c.v. cortagine (3 µg/rat) had lesser effects. Cortagine i.p. also increased colonic permeability, activated proximal and distal colonic myenteric neurons and induced visceral hypersensitivity to a 2nd set of colorectal distention (CRD). The CRF antagonist astressin (10 µg/kg, i.p.) abolished i.p. cortagine-induced hyperalgesia while injected i.c.v. had no effect. In mice, cortagine (30 µg/kg, i.p.) stimulated defecation by 7.8-fold, induced 60% incidence of diarrhea and increased VMR to CRD. Stress-like colonic alterations induced by i.p. cortagine in rats and mice that acts peripherally to induce a CRF1 restricted activation of receptors supports a role of peripheral CRF1 signaling as the local arm of the colonic response to stress.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.